Certara Products Archives

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

CertaraApril 1, 2021

Press Coverage

Legislators: Bring all stakeholders to the table to lower drug costs

BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…

CertaraMarch 30, 2021

On-Demand Webinar

Strategic Evidence & Value Communication Symposium

Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…

CertaraMarch 26, 2021

Case Study

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…

CertaraMarch 2, 2021

Case Study

Early Value Assessment in Gene Therapy Clinical Trial Design

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

CertaraFebruary 12, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

Brochure

BaseCase Interactive for Medical Affairs

CertaraJanuary 28, 2021

Brochure

BaseCase Market Access

CertaraNovember 30, 2020

Press Coverage

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

CertaraNovember 20, 2020

Case Study

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

CertaraNovember 9, 2020

Certara Products

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

Legislators: Bring all stakeholders to the table to lower drug costs

Strategic Evidence & Value Communication Symposium

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

Early Value Assessment in Gene Therapy Clinical Trial Design

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

BaseCase Interactive for Medical Affairs

BaseCase Market Access

Getting Real with RWE

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

Newsletter sign up

Quick links

Solutions

Contact